Cargando…

High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent‐free survival in head and neck squamous cell carcinoma

BACKGROUND: Prolyl 4‐hydroxylase subunit alpha 1 (P4HA1) plays a critical role in modulating the extracellular matrix and promoting tumor progression in various cancers. However, the association between P4HA1 and head and neck squamous cell carcinomas (HNSCC) has not been thoroughly elucidated to da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qun, Shen, Zhisen, Wu, Zhenhua, Shen, Yi, Deng, Hongxia, Zhou, Chongchang, Liu, Huigao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083458/ https://www.ncbi.nlm.nih.gov/pubmed/31782831 http://dx.doi.org/10.1002/jcla.23107

Ejemplares similares

The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2019)

Promoter hypermethylation of CD133/PROM1 is an independent poor prognosis factor for head and neck squamous cell carcinoma
por: Hu, Zele, et al.
Publicado: (2020)

A systematic review and meta-analysis approach on diagnostic value of MLH1 promoter methylation for head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2019)

Construction of a Ferroptosis-Related Gene Signature for Head and Neck Squamous Cell Carcinoma Prognosis Prediction
por: Li, Qun, et al.
Publicado: (2021)

Diagnostic and prognostic value of FOXD1 expression in head and neck squamous cell carcinoma
por: Qiu, Shijie, et al.
Publicado: (2021)

Identification of a new anoikis-related gene signature for prognostic significance in head and neck squamous carcinomas
por: Wei, Zhengyu, et al.
Publicado: (2023)

Expression profile and prognostic value of CXCR family members in head and neck squamous cell carcinoma
por: Shen, Yiming, et al.
Publicado: (2022)

Identification of immune‐related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2022)

The association, clinicopathological significance, and diagnostic value of CDH1 promoter methylation in head and neck squamous cell carcinoma: a meta-analysis of 23 studies
por: Shen, Zhisen, et al.
Publicado: (2016)

CD3D: a prognostic biomarker associated with immune infiltration and immunotherapeutic response in head and neck squamous cell carcinoma
por: Wei, Zhengyu, et al.
Publicado: (2022)

Pyroptosis patterns and immune infiltrates characterization in head and neck squamous cell carcinoma
por: Deng, Hongxia, et al.
Publicado: (2022)

Predicting the prognosis, immune response, and immunotherapy in head and neck squamous cell carcinoma using a novel risk model based on anoikis-related lncRNAs
por: Deng, Hongxia, et al.
Publicado: (2023)

A novel Pyroptosis‐related long non‐coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2022)

Overexpression of TRMT12 may independently predict poor overall survival in patients with head and neck squamous cell carcinoma
por: Wang, Kai, et al.
Publicado: (2019)

Construction of an m6A‐related lncRNA pair prognostic signature and prediction of the immune landscape in head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2021)

ITGA5 is an independent prognostic biomarker and potential therapeutic target for laryngeal squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2022)

Arylsulfatase I is a prognostic biomarker for head and neck squamous cell carcinoma and Pan‐cancer
por: Shen, Yiming, et al.
Publicado: (2022)

Identification and validation of a novel signature based on T cell marker genes to predict prognosis, immunotherapy response and chemotherapy sensitivity in head and neck squamous carcinoma by integrated analysis of single-cell and bulk RNA-sequencing
por: Zhou, Chongchang, et al.
Publicado: (2023)

PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma
por: Sailer, Verena, et al.
Publicado: (2017)

Stereotactic radiosurgery may contribute to overall survival for patients with recurrent head and neck carcinoma
por: Kawaguchi, Koji, et al.
Publicado: (2010)

Impact of age for overall survival in head and neck sarcoma
por: Suzuki, Hidenori, et al.
Publicado: (2023)

Upregulation of SQLE Contributes to Poor Survival in Head and Neck Squamous Cell Carcinoma
por: Li, Jing, et al.
Publicado: (2022)

Nomograms predicting long-term overall survival and cancer-specific survival in head and neck squamous cell carcinoma patients
por: Ju, Jun, et al.
Publicado: (2016)

A Metabolic Gene Signature to Predict Overall Survival in Head and Neck Squamous Cell Carcinoma
por: Wu, Zeng-Hong, et al.
Publicado: (2020)

Identification of a Novel Signature Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma
por: Zheng, Haige, et al.
Publicado: (2021)

A Glycosyltransferase-Related Signature for Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma
por: Wu, Huili, et al.
Publicado: (2022)

Neddylation inhibitor MLN4924 sensitizes head and neck squamous carcinoma cells to (S)-10-hydroxycamptothecin
por: Gu, Shanshan, et al.
Publicado: (2023)

CGB5 expression is independently associated with poor overall survival and recurrence‐free survival in patients with advanced gastric cancer
por: Yang, Yuxin, et al.
Publicado: (2018)

A novel pyroptosis-related gene signature to predict outcomes in laryngeal squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2021)

Gene expression analysis of head and neck squamous cell carcinoma survival and recurrence
por: Zhi, Xu, et al.
Publicado: (2014)

Oral hygiene and the overall survival of head and neck cancer patients
por: Chang, Chan‐Chi, et al.
Publicado: (2019)

Elevated DKK1 expression is an independent unfavorable prognostic indicator of survival in head and neck squamous cell carcinoma
por: Gao, Haihe, et al.
Publicado: (2018)

Epigenetic silencing of SALL3 is an independent predictor of poor survival in head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2017)

Expression of the long noncoding RNA RP11‐169D4.1‐001 in Hypopharyngeal Squamous cell carcinoma tissue and its clinical significance
por: Shen, Zhisen, et al.
Publicado: (2019)

An Inflammation-Immunity Classifier of 11 Chemokines for Prediction of Overall Survival in Head and Neck Squamous Cell Carcinoma
por: Liang, Yushan, et al.
Publicado: (2019)

Low expression of RalGAPs associates with the poorer overall survival of head and neck squamous cell carcinoma
por: Liu, Shan, et al.
Publicado: (2021)

tRNA(Ini) (CAT) inhibits proliferation and promotes apoptosis of laryngeal squamous cell carcinoma cells
por: Li, Jun, et al.
Publicado: (2021)

The expression profile and clinical application value of hsa_circ_0016148 in head and neck squamous cell carcinoma
por: Shen, Zhisen, et al.
Publicado: (2021)

PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma
por: Sailer, Verena, et al.
Publicado: (2016)

Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma
por: Xu, Yuanyuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v49tbo2qi3bp6nies65rn7e1r4